在成熟的B细胞中减少PU.1表达会诱导淋巴发育
Shinya Endo1, Nao Nishimura1, Kosuke Toyoda1
1Department of Hematology, Rheumatology, and Infectious Disease, Kumamoto University Graduate School of Medicine, Kumamoto, Japan.
Cancer science
|September 25, 2024
概括
转录因子PU.1 (Spi1) 的表达减少与成熟的B细胞淋巴瘤的发展有关. 在小鼠中,PU.1功能的丧失促进了淋巴瘤的形成,这表明它在B细胞中的瘤抑制作用.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的非霍奇金淋巴瘤,但其淋巴发生机制尚未完全理解.
- 埃特斯家族的转录因子PU.1 (由Spi1编码) 对于髓状和淋巴状细胞的发育至关重要.
- 以前的研究表明PU.1在其他血液性恶性瘤中具有瘤抑制作用.
研究的目的:
- 调查PU.1在DLBCL病变发生中的作用.
- 为了确定是否减少PU.1表达有助于成熟的B细胞淋巴瘤 in vivo的发展.
主要方法:
- 在DLBCL患者样本中分析PU.1表达.
- 使用Cγ1-Cre.使用条件Spi1淘汰赛小鼠的生成.
- 组织病理学检查和RNA测序的淋巴瘤从淘汰赛小鼠.
- 淋巴瘤细胞的体内移植测定和Spi1转导的救援实验.
主要成果:
- DLBCL患者,特别是非GCB亚型患者,显示PU.1表达显著减少.
- 在小鼠中,Spi1的有条件淘汰导致了56%的B细胞淋巴瘤的发展.
- 将这些淋巴瘤移植到接受者小鼠中导致了快速死亡,Spi1重新引入部分挽救了这种死亡.
结论:
- 在成熟的B细胞中,PU.1充当瘤抑制剂.
- 降低PU.1的调节与成熟的B细胞淋巴瘤的发展有关,包括DLBCL.
更多相关视频
11:40Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
8.5K
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
5.0K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Cells of the Adaptive Immune Response
970
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
970
